Nucleic Acids Research, 1992, Vol. 20, No. 23 6363-6368
© 1992
MOLECULAR BIOLOGY |
Repair synthesis by human cell extracts in cisplatin damaged DNA is preferentially determined by minor adducts
Laboratoire de Pharmacologie et Toxicologie Fondamentales du CNRS 205 route de Narbonne, 31400 Toulouse, France
*To whom correspondence should be addressed
Received August 7, 1992. Revised November 9, 1992. Accepted November 9, 1992.
During reaction of cis-diamminedichloroplatinum(II) (cis-DDP) with DNA, a number of adducts are formed which may be discriminated by the excision-repair system. An in vitro excision-repair assay with human cell-free extracts has been used to assess the relative repair extent of monofunctional adducts, intrastrand and interstrand cross-links of cis-DDP on plasmid DNA. Preferential removal of cis-DDP 1,2-intrastrand diadducts occurred in the presence of cyanide ions. In conditions where cyanide treatment removed 85% of total platinum adducts while 
70% of interstrand cross-links remained in plasmid DNA, no significant variation in repair synthesis by human cell extracts was observed. Then, we constructed three types of plasmid DNA substrates containing mainly either monoadducts, 1,2-intrastrand cross-links or interstrand cross-links lesions. The three plasmid species were modified in order to obtain the same extent of total platinum DNA adducts per plasmid. No DNA repair synthesis was detected with monofunctional adducts during incubation with human whole cell extracts. However, a two-fold increase in repair synthesis was found when the proportion of interstrand cross-links in plasmid DNA was increased by 2–3 fold. These findings suggest that (i) cis-DDP 1,2-intrastrand diadducts are poorly repaired by human cell extracts in vitro, (ii) among other minor lesions potentially cyanide-resistant, cis-DDP interstrand cross-links represent a major lesion contributing to the repair synthesis signal in the in vitro assay. These results could account for the drug efficiency in vivo.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Novakova, J. Kasparkova, J. Malina, G. Natile, and V. Brabec DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes Nucleic Acids Res., November 15, 2003; 31(22): 6450 - 6460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Buterin, M. T. Hess, D. Gunz, N. E. Geacintov, L. H. Mullenders, and H. Naegeli Trapping of DNA Nucleotide Excision Repair Factors by Nonrepairable Carcinogen Adducts Cancer Res., August 1, 2002; 62(15): 4229 - 4235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. CANITROT, J.-S. HOFFMANN, P. CALSOU, H. HAYAKAWA, B. SALLES, and C. CAZAUX Nucleotide excision repair DNA synthesis by excess DNA polymerase {beta}: a potential source of genetic instability in cancer cells FASEB J, September 1, 2000; 14(12): 1765 - 1774. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Krueger, L. H.F. Mullenders, and A. Hartwig Nickel(II) increases the sensitivity of V79 Chinese hamster cells towards cisplatin and transplatin by interference with distinct steps of DNA repair Carcinogenesis, July 1, 1999; 20(7): 1177 - 1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Hoffmann, M.-J. Pillaire, D. Garcia-Estefania, S. Lapalu, and G. Villani In Vitro Bypass Replication of the Cisplatin-d(GpG) Lesion by Calf Thymus DNA Polymerase beta and Human Immunodeficiency Virus Type I Reverse Transcriptase Is Highly Mutagenic J. Biol. Chem., June 28, 1996; 271(26): 15386 - 15392. [Abstract] [Full Text] [PDF]
|
|